{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T06:38:52Z","timestamp":1769841532575,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["transplantation-proceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.transproceed.2014.09.010","type":"journal-article","created":{"date-parts":[[2014,11,7]],"date-time":"2014-11-07T17:31:24Z","timestamp":1415381484000},"page":"2908-2911","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Fatal Late-Onset Pneumocystis Pneumonia After Rituximab: Administration for Posttransplantation Recurrence of Focal Segmental Glomerulosclerosis\u2014Case Report"],"prefix":"10.1016","volume":"46","author":[{"given":"D.","family":"D\u0119borska-Materkowska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Kozi\u0144ska-Przyby\u0142","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mikaszewska-Sokolewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Durlik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2014.09.010_bib1","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0002-9343(92)90267-F","article-title":"Recurrent focal glomerulosclerosis: natural history and response to therapy","volume":"92","author":"Artero","year":"1992","journal-title":"Am J Med"},{"key":"10.1016\/j.transproceed.2014.09.010_bib2","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1600-6143.2005.00968.x","article-title":"New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis","volume":"5","author":"Vincenti","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2014.09.010_bib3","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/S0272-6386(03)00364-0","article-title":"Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin","volume":"41","author":"Bertelli","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2014.09.010_bib4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1432-2277.2009.00977.x","article-title":"Long-term outcome of renal transplantation in adults with focal segmental glomerulosclerosis","volume":"23","author":"Moroni","year":"2010","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2014.09.010_bib5","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1517\/14656566.6.9.1539","article-title":"Treatment of focal segmental glomerulosclerosis","volume":"6","author":"Mayrier","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.transproceed.2014.09.010_bib6","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/TP.0b013e3181aed9d7","article-title":"Use of rituximab in focal glomerulosclerosis relapses after renal transplantation","volume":"3","author":"Dello Strologo","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2014.09.010_bib7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00467-012-2286-6","article-title":"Atypical Pneumocystis jirovecii pneumonia with multiple nodular granulomas after rituximab for refractory nephrotic syndrome","volume":"28","author":"Sato","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.transproceed.2014.09.010_bib8","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/j.1440-1797.2009.01168.x","article-title":"Late onset Pneumocystis pneumonia in patients receiving rituximab for humoral renal transplant rejection","volume":"14","author":"Shelton","year":"2009","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.transproceed.2014.09.010_bib9","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3109\/10428191003699860","article-title":"High incidence of Pneumocystis jirovecii pneumonia in patients receiving biweekly rituximab and cyclophosphamide, Adriamycin, vincristine, and prednisone","volume":"51","author":"Kamel","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.transproceed.2014.09.010_bib10","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.3109\/10428190903258780","article-title":"Addition of rituximab to cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy has a high risk of developing interstitial pneumonia in patients with non-Hodgkin lymphoma","volume":"50","author":"Katsuya","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.transproceed.2014.09.010_bib11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1399-3062.2008.00345.x","article-title":"Pneumocystis jirovecii pneumonia after rituximab therapy for antibody mediated rejection in a renal transplant recipient","volume":"11","author":"Kumar","year":"2009","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.transproceed.2014.09.010_bib12","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1086\/515126","article-title":"Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued?","volume":"28","author":"Gordon","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.transproceed.2014.09.010_bib13","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1093\/cid\/cir996","article-title":"A\u00a0cluster of Pneumocystis infections among renal transplant recipients: molecular evidence of colonized patients as potential infectious sources of Pneumocystis jirovecii","volume":"54","author":"Le Gal","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.transproceed.2014.09.010_bib14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/ki.2009.377","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary","volume":"77","author":"Kasiske","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2014.09.010_bib15","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/TP.0b013e3181aed389","article-title":"Outbreak of Pneumocystis jirovecii pneumonia in renal transplant recipients: P.\u00a0jirovecii is contagious to the susceptible host","volume":"88","author":"Yazaki","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2014.09.010_bib16","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1399-3062.2011.00645.x","article-title":"Risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients and appraisal of strategies for selective use of chemoprophylaxis","volume":"13","author":"de Boer","year":"2011","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.transproceed.2014.09.010_bib17","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/archsurg.1987.01400210072010","article-title":"Cyclosporine therapy and refractory Pneumocystis carinii pneumonia. A potential association","volume":"122","author":"Franson","year":"1987","journal-title":"Arch Surg"},{"key":"10.1016\/j.transproceed.2014.09.010_bib18","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.4049\/jimmunol.133.5.2502","article-title":"Lymphocyte changes during chronic administration of and withdrawal from corticosteroids: relation to Pneumocystis carinii pneumonia","volume":"133","author":"Walzer","year":"1984","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.transproceed.2014.09.010_bib19","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1086\/323129","article-title":"Prevention of infection caused by Pneumocystis carinii in transplant recipients","volume":"33","author":"Fishman","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.transproceed.2014.09.010_bib20","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000082102","article-title":"The biology of CD20 and its potential as a target for mAb therapy","volume":"8","author":"Cragg","year":"2005","journal-title":"Curr Dir Autoimmun"},{"key":"10.1016\/j.transproceed.2014.09.010_bib21","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1007\/s00467-005-2013-7","article-title":"Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephritic syndrome","volume":"20911","author":"Nozu","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.transproceed.2014.09.010_bib22","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1097\/TP.0b013e31819f12be","article-title":"Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence","volume":"87","author":"Hickson","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2014.09.010_bib23","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1046\/j.1526-0968.2002.00297.x","article-title":"The effectiveness of intravenous human immunoglobulin treatment after plasmapheresis in restoring serum immunoglobulin levels: a preliminary study","volume":"6","author":"Moriya","year":"2002","journal-title":"Ther Apher"},{"key":"10.1016\/j.transproceed.2014.09.010_bib24","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.4049\/jimmunol.171.3.1423","article-title":"Clearance of Pneumocystis carinii in mice is dependent on B cells but not on P.\u00a0carinii-specific antibody","volume":"171","author":"Lund","year":"2003","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.transproceed.2014.09.010_bib25","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.4049\/jimmunol.176.10.6147","article-title":"B\u00a0cells are required for generation of protective effector and memory CD4 cells in response to Pneumocystis lung infection","volume":"176","author":"Lund","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.transproceed.2014.09.010_bib26","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1002\/art.24998","article-title":"Depletion of functionally active CD20 T cells by rituximab treatment","volume":"60","author":"Wilk","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.transproceed.2014.09.010_bib27","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/10428190902730219","article-title":"Infectious complications of rituximab in patients with lymphoma during maintenance therapy: a systematic review and meta-analysis","volume":"50","author":"Aksoy","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.transproceed.2014.09.010_bib28","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3324\/haematol.10564","article-title":"Pneumocystis jirovecii pneumonia in B-cell lymphoma patients treated with the rituximab-CHOEP-14 regimen","volume":"92","author":"Kolstad","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.transproceed.2014.09.010_bib29","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000334113","article-title":"The increased risk for pneumocystis pneumonia in patients receiving rituximab-CHOP-14 can be prevented by the administration of trimethoprim\/sulfamethoxazole: a single-center experience","volume":"127","author":"Hardak","year":"2012","journal-title":"Acta Haematol"},{"key":"10.1016\/j.transproceed.2014.09.010_bib30","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/01.tp.0000296122.19026.0f","article-title":"Pharmacodynamics of rituximab in kidney transplantation","volume":"27","author":"Genberg","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2014.09.010_bib31","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1399-0012.2007.00700.x","article-title":"Infectious complications associated with the use of rituximab for ABO-incompatible and positive cross-match renal trans plant recipients","volume":"21","author":"Grim","year":"2007","journal-title":"Clin Transplant"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134514007969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134514007969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T00:01:20Z","timestamp":1689638480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134514007969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0041134514007969"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2014.09.010","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fatal Late-Onset Pneumocystis Pneumonia After Rituximab: Administration for Posttransplantation Recurrence of Focal Segmental Glomerulosclerosis\u2014Case Report","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2014.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}